DRUG DELIVERY PLATFORM – VitalDose® EVA Implants for Systemic
Drug Development & Delivery,
LIMITATIONS OF CONVENTIONAL DELIVERY METHODS As the pharmaceutical development landscape continues to evolve, the search for…
LIMITATIONS OF CONVENTIONAL DELIVERY METHODS As the pharmaceutical development landscape continues to evolve, the search for…
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, announced that the US Food and Drug…
(Image Credit: AdobeStock/wladimir1804) Glaukos Corp announced the FDA has approved its New Drug Application (NDA) for a single…